Home › Funds › Palo Alto Investors LP › XERS
Palo Alto Investors LP position in XERS
XERIS BIOPHARMA HOLDINGS INC · Health Care
Palo Alto Investors LP reported holding 104,410 shares of XERS (XERIS BIOPHARMA HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$998K, representing 0.15% of its reported portfolio and ranking #48 among its reported holdings. Palo Alto Investors LP has disclosed XERS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's XERS position evolved
Palo Alto Investors LP first disclosed a stake in XERS in Q1 2026 at 104,410 shares (US$606K). The position peaked in Q3 2026 at 104,410 shares, worth US$998K. Across 3 filings, Palo Alto Investors LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 104,410 shares valued at US$998K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 104.41K | $605.58K | New |
| Q2 2026 | 104.41K | $826.93K | Hold |
| Q3 2026 | 104.41K | $998.16K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XERS and 13F data
XERS (XERIS BIOPHARMA HOLDINGS INC) is a Health Care company. 51 other funds we track also report a position in XERS — the largest reported positions include Parkman Healthcare Partners LLC (US$15.7M), Vilga Financial Planning LLC (US$10.1M), Knott David M Jr (US$9.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XERS
- Parkman Healthcare Partners LLC 1.64M sh · $15.70M · Q3 2026
- Vilga Financial Planning LLC 1.06M sh · $10.13M · Q3 2026
- Knott David M Jr 1.00M sh · $9.59M · Q3 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 693.26K sh · $6.63M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held XERS?
Palo Alto Investors LP has disclosed XERS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Palo Alto Investors LP's current position in XERS?
As of Q3 2026, Palo Alto Investors LP holds 104.41K shares of XERS (XERIS BIOPHARMA HOLDINGS INC), valued at $998.16K, representing 0.15% of its reported portfolio and ranking #48.
Has Palo Alto Investors LP been buying or selling XERS?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP held unchanged its position in XERS. The position peaked in Q3 2026 at 104.41K shares.
Which other funds hold XERS?
Other major institutional holders of XERS include Parkman Healthcare Partners LLC, Vilga Financial Planning LLC, Knott David M Jr, among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.